Assistant Research Professor
DVM, University of Missouri
Residency (Laboratory Animal Medicine), MU Comparative Medicine Program
PhD (Area Pathobiology), University of Missouri
Building Address: S123B Discovery Ridge Building
Phone Number: 573-882-1019
Research Emphasis: gut microbiota, metagenomics, mucosal immunology, pathology, comparative medicine, translational medicine
Our lab is interested in differences in the composition of the gut microbiota in inbred strains and outbred stocks of mice and rats, factors that drive those differences, and the impact of the resulting enterotypes on rodent models of disease, particularly models of colitis and colitis-associated colorectal cancer. Using rederivation via embryo transfer and fecal microbiota transfer, we modulate the gut microbiota at birth or later in life respectively, to investigate windows of vulnerability for modulation of the gut microbiota. Next-generation sequencing platforms are used to characterize the gut microbiota. We’re also interested in the mechanisms through which certain microbes, such as segmented filamentous bacteria, affect the ontogeny of the host immune system. Additionally, we collaborate with clinical veterinarians to examine associations between characteristics of the gut, respiratory, and dermal microbiota and various conditions affecting dogs, cats, horses, and cattle.
Miller, P.G., Bonn, M.B., Franklin, C.L., Ericsson, A.C., and S.C. McKarns. (2015) TNFR2 Deficiency Acts in Concert with Gut Microbiota to Precipitate Sex-biased Spontaneous CNS Demyelinating Autoimmune Disease. Journal of Immunology, 195(10): 4668-4684.
Hart, M.L., Meyer, A., Johnson, P.J., and A.C. Ericsson. (2015) Comparative Evaluation of DNA Extraction Methods from Feces of Multiple Host Species for Downstream Next-Generation Sequencing. PLoS One, 10(11): e0143334.
Amos-Landgraf, J., Busi, S., Ericsson, A., McCoy, M., Parker, T., Schehr, R., Hankins, M., Franklin, C., and E.C. Bryda. (2015) Abstract 2880: Modulating disease susceptibility in a model of human colon cancer by microbiome rederivation. Cancer Research 75 (15 suppl): abstract 2880.
Ericsson, A.C., Akter, S., Hanson, M., Busi, S.B., Parker, T., Schehr, R., Hankins, M., Ahner, C.E., Davis, J.W., Franklin, C.L., Amos-Landgraf, J., and E.C. Bryda. (2015) Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota. Oncotarget, 6(32): 33689-33704.
Ericsson, A.C., Turner, G., Montoya, L., Wolfe, A., Meeker, S., Hsu, C., Maggio-Price, L., and C.L. Franklin. (2015) Isolation of segmented filamentous bacteria from a complex gut microbiota. BioTechniques, 59(2): 94-98.
Ericsson, A.C., Davis, D.J., Franklin, C.L., and C.E. Hagan. (2015) Exoelectrogenic capacity of host microbiota predicts lymphocyte recruitment to the gut. Physiological Genomics, 47(7): 243-252.
Ericsson, A.C., and C.L. Franklin. (2015) Manipulating the gut microbiota: methods and challenges. ILAR Journal, 56(2): 205-217. (invited review)
Ericsson, A.C., Davis, J.W., Spollen, W., Bivens, N., Givan, S., Hagan, C.E., McIntosh, M., and C.L. Franklin. (2015) Effects of vendor and genetic background on the composition of the gut microbiota of inbred mice. PLoS ONE, 10(2): e0116704.
Sands, S.A., Tsau, S., Yankee, T.M., Parker, B.L., Ericsson, A.C., and S.M. Levine. (2014) The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. BMC Research Notes, 7(1): 605-615.
Ericsson, A.C., Hagan, C., Davis, D.J., and C. L. Franklin. (2014) A review of segmented filamentous bacteria – commensal microbes with potential effects on research. Comparative Medicine, 64(2): 90-98.
Ericsson, A.C., Crim, M., and C.L. Franklin. (2013) A brief history of animal modeling. Missouri Medicine. 110(3): 201-205.
Lee, K., Kwon, D-N., Ericsson, A., Brown, A.N., Samuel, M., Park, K-W., Walters, E., Kim, J-H., Franklin, C., Murphy, C.N., Prather, R.S., and J-H. Kim. (2013) Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency. Proceedings of the National Academy of Sciences, 111(20): 7260-7265.
Ortega-Cava, C.F., Raja, S.M., Laiq, Z., Bailey, T.A., Luan, H., Mohapatra, B., Williams, S.H., Ericsson, A.C., Goswami, R., Dimri, M., Duan, L., Band, V., Naramura, M., and H. Band. (2011) Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer. Journal of Carcinogenesis, 10(29).
Ghosh, S., Koblinski, J., Johnson, J., Liu, Y., Frazier, S., Ericsson, A., Shi, Z., Crawford, S., and M.S. Stack. (2010) Urinary-type plasminogen activator receptor (uPAR/R)/alpha3beta1 integrin signaling and oral tumor progression. Molecular Cancer Research, 8(2):145-158.
Ericsson, A., Myles, M., Davis, J.W., Ma, L., Lewis, M., Maggio-Price, L., and C. Franklin. (2010) Noninvasive detection of inflammation-associated colon cancer in a mouse model. Neoplasia, 12(12): 1054-1065.